Alcoholism-Clinical and Experimental Research

Papers
(The H4-Index of Alcoholism-Clinical and Experimental Research is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
RSA/ISBRA Program Outline104
List of 2021 Reviewers83
Issue Information54
Persistence of cerebellar ataxia during chronic ethanol exposure is associated with epigenetic up‐regulation ofFmr1gene expression in rat cerebellum51
Screening for hazardous alcohol use in the Emergency Department: Comparison of phosphatidylethanol with the Alcohol Use Disorders Identification Test and the Timeline Follow‐back46
Maternal binge alcohol consumption leads to distinctive acute perturbations in embryonic cardiac gene expression profiles39
Longitudinal assessment of drinking changes during the pandemic: The 2021 COVID‐19 follow‐up study to the 2019 to 2020 National Alcohol Survey38
Choline supplementation as an intervention for fetal alcohol spectrum disorders: A commentary38
Within‐ and between‐person effects of naltrexone on the subjective response to alcohol and craving: A daily diary investigation37
Systematic review and meta‐analysis on the association between theory of mind and alcohol problems in non‐clinical samples35
Effect of intravenous ghrelin administration, combined with alcohol, on circulating metabolome in heavy drinking individuals with alcohol use disorder35
Abstinence versus moderation recovery pathways following resolution of a substance use problem: Prevalence, predictors, and relationship to psychosocial well‐being in a U.S. national sample30
Author Index29
A meta‐regression of methodological features that predict the effects of medications on the subjective response to alcohol28
History of healthcare use and disease burden in older adults with different levels of alcohol use. A register‐based cohort study28
Is extended release naltrexone superior to buprenorphine‐naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial28
Issue Information28
Issue Information27
27
Development of the motivational thought frequency scale for alcohol abstinence (MTF‐A)26
A Western diet with alcohol in drinking water recapitulates features of alcohol‐associated liver disease in mice24
COVID‐19 patients with documented alcohol use disorder or alcohol‐related complications are more likely to be hospitalized and have higher all‐cause mortality22
Prenatal alcohol exposure exacerbates acute sensorimotor deficits and impedes long‐term behavioral recovery from the effects of an adult‐onset cerebrovascular ischemic stroke22
0.11952304840088